AR214303A1 - Un procedimiento para preparar nuevos derivados de(cicloalquilalquiloxi-(o tio,o-sulfonil-alquil)-(o alquiloxi fenoxi)-1amino-3-propanol-2 - Google Patents

Un procedimiento para preparar nuevos derivados de(cicloalquilalquiloxi-(o tio,o-sulfonil-alquil)-(o alquiloxi fenoxi)-1amino-3-propanol-2

Info

Publication number
AR214303A1
AR214303A1 AR265315A AR26531576A AR214303A1 AR 214303 A1 AR214303 A1 AR 214303A1 AR 265315 A AR265315 A AR 265315A AR 26531576 A AR26531576 A AR 26531576A AR 214303 A1 AR214303 A1 AR 214303A1
Authority
AR
Argentina
Prior art keywords
alkyloxyphenoxy
1amine
cycloalkylalkyloxy
thio
sulfonyl
Prior art date
Application number
AR265315A
Other languages
English (en)
Spanish (es)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of AR214303A1 publication Critical patent/AR214303A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
AR265315A 1975-11-06 1976-11-02 Un procedimiento para preparar nuevos derivados de(cicloalquilalquiloxi-(o tio,o-sulfonil-alquil)-(o alquiloxi fenoxi)-1amino-3-propanol-2 AR214303A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7533899A FR2330383A1 (fr) 1975-11-06 1975-11-06 Nouveaux ethers de phenols substitues, leurs sels, leur preparation et les medicaments qui les renferment

Publications (1)

Publication Number Publication Date
AR214303A1 true AR214303A1 (es) 1979-05-31

Family

ID=9162099

Family Applications (1)

Application Number Title Priority Date Filing Date
AR265315A AR214303A1 (es) 1975-11-06 1976-11-02 Un procedimiento para preparar nuevos derivados de(cicloalquilalquiloxi-(o tio,o-sulfonil-alquil)-(o alquiloxi fenoxi)-1amino-3-propanol-2

Country Status (24)

Country Link
US (2) US4252984A (pt)
JP (1) JPS5848543B2 (pt)
AR (1) AR214303A1 (pt)
AT (1) AT344683B (pt)
AU (1) AU501581B2 (pt)
BE (1) BE847801A (pt)
CA (1) CA1072981A (pt)
CH (1) CH602582A5 (pt)
DE (1) DE2649605C3 (pt)
DK (1) DK145119C (pt)
ES (1) ES452920A1 (pt)
FI (1) FI62829C (pt)
FR (1) FR2330383A1 (pt)
GB (1) GB1515978A (pt)
GR (1) GR61363B (pt)
IE (1) IE43645B1 (pt)
IL (1) IL50814A (pt)
LU (1) LU76117A1 (pt)
NL (1) NL179051C (pt)
NO (1) NO142034C (pt)
NZ (1) NZ182498A (pt)
PT (1) PT65780B (pt)
SE (1) SE433208B (pt)
ZA (1) ZA766338B (pt)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2409980A1 (fr) * 1977-11-24 1979-06-22 Synthelabo Ethers de phenols et leur application en therapeutique
IT1147311B (it) * 1980-02-13 1986-11-19 Stabil Bioterapico Farmachim Eteri basici di 4-idrossi-benzofenoni con attivita' quali agenti betabloccanti e relativi procedimento di preparazione
ZW9881A1 (en) * 1980-06-02 1981-12-23 Hoffmann La Roche Substituted phenoxyaminopropanol derivatives
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
CH643527A5 (en) * 1980-10-24 1984-06-15 Ciba Geigy Ag Process for the preparation of 1-alkylamino-3-(4-(2-lower alkoxy-ethyl)phenoxy)-2-propanols
US5347050A (en) * 1980-11-06 1994-09-13 Richard Berthold 3-aminopropoxyphenyl derivatives, their preparation and pharmaceutical compositions containing them
JPS57108047A (en) * 1980-11-06 1982-07-05 Sandoz Ag 3-aminopropoxyphenyl derivative, manufacture and pharmaceutical composition containing same
FI76551C (fi) 1980-11-06 1988-11-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.
DE3125636A1 (de) * 1981-06-30 1983-01-13 Merck Patent Gmbh, 6100 Darmstadt 1-(p-2-isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol zur senkung des augeninnendrucks und ophtalmikum, enthalten diese verbindung
FR2512443A1 (fr) * 1981-09-10 1983-03-11 Synthelabo Derives de phenoxy-3 propanol-2, leur preparation et leur application en therapeutique
DE3151201A1 (de) * 1981-12-23 1983-07-28 Beiersdorf Ag, 2000 Hamburg Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte
US4450172A (en) * 1982-03-10 1984-05-22 E. I. Du Pont De Nemours And Company Antihypertensive polyhalohydroxyisopropyl phenylalka(e)noic acid esters of alkylaminohydroxypropyloxyphenylalkyl alcohols
FR2536390B1 (fr) * 1982-11-22 1986-03-21 Synthelabo Isomere s du betaxolol, sa preparation et son application en therapeutique
US5166218A (en) * 1983-10-19 1992-11-24 Hoffmann-La Roche Inc. Phenoxypropanolamines and pharmaceutical compositions thereof
CA1262729A (en) * 1983-10-19 1989-11-07 Leo Alig Phenoxypropanolamines
ZA852843B (en) * 1984-05-15 1985-11-27 Warner Lambert Co Bevantolol preparation
GB8412864D0 (en) * 1984-05-19 1984-06-27 Smith Kline French Lab Chemical compounds
US5554367A (en) * 1984-10-31 1996-09-10 Alcon Laboratories, Inc. Compositions for treatment of glaucoma
ES8609190A1 (es) * 1985-02-07 1986-07-16 Pharma Investi S A Un procedimiento para preparar eteres fenolicos
US5095151A (en) * 1985-05-21 1992-03-10 American Home Products Corporation Preparation of propranolol hydrochloride macrocrystals
EP0252007A3 (en) * 1986-06-28 1989-07-05 Ciba-Geigy Ag 2-propanol derivatives as corrosion inhibitors
US4694022A (en) * 1986-12-24 1987-09-15 Alcon Laboratories, Inc. Fatty acid salts of betaxolol useful in the treatment of glaucoma
DE3866984D1 (en) * 1987-07-21 1992-01-30 Hoffmann La Roche Phenoxypropanolamine.
FR2672594B1 (fr) * 1991-02-08 1994-07-01 Synthelabo Derives d'ethers de phenols, leur preparation et leur application en therapeutique.
DE69632078T2 (de) * 1995-10-10 2004-09-16 Louis, William John, Rosanna 3-aminopropoxyphenyl-derivate
CA2193149C (en) * 1995-12-22 2002-04-23 David H. Donabedian Cationic therapuetic agents and delivery systems
US5942633A (en) * 1996-06-19 1999-08-24 Abbott Laboratories Process for the selective alkylation of betaxolol intermediates
US5731463A (en) * 1996-09-23 1998-03-24 Abbott Laboratories Selective alkylation of an alcohol substituted phenol compound
CA2330611A1 (en) 1998-05-22 1999-12-02 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US7081482B2 (en) * 1999-11-30 2006-07-25 Alcon, Inc. Use of β-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
JP2004511435A (ja) * 2000-07-27 2004-04-15 ファルマシア・コーポレーション うっ血性心不全の処置のための、エポキシ−ステロイド型アルドステロン拮抗薬とβ−アドレナリン作動性拮抗薬の併用療法
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
CN1681495B (zh) 2002-08-19 2010-05-12 辉瑞产品公司 用于治疗过度增生性疾病的组合物
WO2004106299A2 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Substituted pyrrole derivatives and their use as hmg-co inhibitors
CN1300079C (zh) * 2004-12-03 2007-02-14 南京大学 合成4－[2－(环丙基甲氧基)乙基]苯酚的新工艺
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
KR101329112B1 (ko) * 2005-11-08 2013-11-14 랜박시 래보러터리스 리미티드 (3ｒ,5ｒ)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008020314A2 (en) * 2006-03-14 2008-02-21 Ranbaxy Laboratories Limited Statin stabilizing dosage formulations
MX2009000439A (es) * 2006-07-14 2009-02-04 Ranbaxy Lab Ltd Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas.
US20080161324A1 (en) * 2006-09-14 2008-07-03 Johansen Lisa M Compositions and methods for treatment of viral diseases
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
AU2008220104B2 (en) 2007-02-28 2012-09-27 Asahi Kasei Pharma Corporation Sulfonamide derivative
US9782488B2 (en) 2007-03-12 2017-10-10 Nektar Therapeutics Oligomer-beta blocker conjugates
EP2050441A1 (en) * 2007-10-19 2009-04-22 Université Victor Segalen Bordeaux 2 Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
US8987262B2 (en) 2007-10-19 2015-03-24 Universite de Bordeaux Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas
JP2009040769A (ja) * 2008-07-09 2009-02-26 William John Louis ３−アミノ−プロポキシフェニル誘導体（ｉ）
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP2427178B1 (en) 2009-05-06 2023-01-04 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN113574055A (zh) 2019-01-18 2021-10-29 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT323132B (de) * 1935-11-15 1975-06-25 Boehringer Sohn Ingelheim Verfahren zur herstellung von neuen racemischen oder optisch aktiven n,n'-bis-(3-subst.phenoxy-2-hydroxy-1-propyl)-alpha,omega-diaminoalkanen sowie deren saureadditionssalzen
GB1078852A (en) * 1964-09-30 1967-08-09 Ici Ltd Alkanolamine derivatives
CA956632A (en) * 1969-05-16 1974-10-22 Yoshitomi Pharmaceutical Industries Phenoxy-aminopropanol derivatives
SE372762B (pt) * 1969-05-21 1975-01-13 Haessle Ab
US3712890A (en) * 1969-06-20 1973-01-23 Ici Ltd Process for making 2-aryloxymethyl morpholines
SE354851B (pt) * 1970-02-18 1973-03-26 Haessle Ab
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives

Also Published As

Publication number Publication date
ES452920A1 (es) 1977-11-01
BE847801A (fr) 1977-02-14
PT65780A (fr) 1976-12-01
JPS5848543B2 (ja) 1983-10-28
NL179051C (nl) 1986-07-01
US4311708A (en) 1982-01-19
LU76117A1 (pt) 1978-07-10
CH602582A5 (pt) 1978-07-31
AT344683B (de) 1978-08-10
DE2649605B2 (de) 1980-07-10
NO142034C (no) 1980-06-18
IE43645B1 (en) 1981-04-22
IL50814A0 (en) 1977-01-31
ATA812076A (de) 1977-12-15
DE2649605A1 (de) 1977-05-18
JPS5285146A (en) 1977-07-15
NL7612123A (nl) 1977-05-10
FR2330383B1 (pt) 1979-09-21
CA1072981A (en) 1980-03-04
AU501581B2 (en) 1979-06-21
GR61363B (en) 1978-10-30
IL50814A (en) 1979-11-30
FR2330383A1 (fr) 1977-06-03
IE43645L (en) 1977-05-06
NZ182498A (en) 1978-04-03
DK145119B (da) 1982-09-06
NO763732L (no) 1977-05-09
AU1925976A (en) 1978-05-11
SE433208B (sv) 1984-05-14
DK495476A (da) 1977-05-07
SE7612177L (sv) 1977-05-07
NO142034B (no) 1980-03-10
PT65780B (fr) 1978-05-10
ZA766338B (en) 1977-10-26
NL179051B (nl) 1986-02-03
FI763132A (pt) 1977-05-07
DK145119C (da) 1983-02-14
DE2649605C3 (de) 1981-04-02
FI62829B (fi) 1982-11-30
US4252984A (en) 1981-02-24
FI62829C (fi) 1983-03-10
GB1515978A (en) 1978-06-28

Similar Documents

Publication Publication Date Title
AR214303A1 (es) Un procedimiento para preparar nuevos derivados de(cicloalquilalquiloxi-(o tio,o-sulfonil-alquil)-(o alquiloxi fenoxi)-1amino-3-propanol-2
AR225878A1 (es) Nuevos derivados de 3-amino-2-azetidinon-1-((2-halo-acetil o 2-haloetiliden))-acetico,procedimiento para prepararlos y procedimiento para obtener compuestos 3-cefem a partir de dichos derivados
PT67906B (pt) Processo para a preparacao de derivados cefemicos.
ES484097A0 (es) Un procedimiento para la preparacion de nuevos derivados de-4-anilinoquinazolinas
ES488678A0 (es) Un procedimiento para la preparacion de nuevos derivados he-terociclicos
BR7607104A (pt) Processo para a preparacao de derivados de sub-produtos celulogicos agricolas
ES488386A0 (es) Un procedimiento para preparar nuevos derivados heterocicli-cos
BR7804679A (pt) Processo para a preparacao de derivados de 1,2,4-triazina-5-ona
AR225727A1 (es) Procedimiento para la obtencion de nuevos derivados de interfennilen-8-aza-9-dioxotia-11,12-seco-prostaglandina
AR225666A1 (es) Procedimiento para la produccion de derivados para la produccion de derivados de 1-alquil-1-alquenil,alcoxi o alquil-3-5-alquil,fenil o halo-3-isoxazolilourea
IT1063101B (it) Preparazione di floruri di zolfo
BR7602452A (pt) Processo para a preparacao de derivados de piperidina
AR217652A1 (es) Procedimiento para preparar un derivado de 8a-hidroxi o clorooleandomicina
AR220730A1 (es) Procedimiento para la preparacion de nuevos derivados de la i-((benzoxatiolil)-metil)-4-heterociclil-piperazina
BR7604436A (pt) Processo para a preparacao de derivados de benzil-nitrila substituidos
MX4858E (es) Procedimiento para preparar compuestos de bis-carbamilguanidino-aza-alcano
AR211856A1 (es) Procedimiento para producir derivados de 5-metil-1-fenil-1,3,4,6,-tetrahidro-5h-benzf2,5,-oxazocina
ES528066A0 (es) Procedimiento para preparar nuevos derivados del azabiciclo heptano.
IT1085596B (it) Perfezionamento al procedimento per preparare vitamina a partendo da solfoni
BR7605392A (pt) Processo para preparacao de um fosforo-dicloreto-tiolato
BR7603968A (pt) Processo para preparacao de derivados de 4-(benzoil-pirazol)
AR209948A1 (es) Procedimiento para la produccion de nuevos compuestos de ferroceno
AR208631A1 (es) Perfeccionamientos para la depuracion de soluciones sulfuricas diluidas
NL7804911A (nl) 2-trichloormethyl-4-nitrobenzeensulfeenzuurderivaten.
AR215869A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-fenil-2-aminoetanol